| Whole-genome sequencing coupled to imputation discovers genetic signals for anthropometric traits I Tachmazidou, D Süveges, JL Min, GRS Ritchie, J Steinberg, K Walter, ... The American Journal of Human Genetics 100 (6), 865-884, 2017 | 250* | 2017 |
| Extracellular vesicle-transported Semaphorin3A promotes vascular permeability in glioblastoma L Treps, S Edmond, E Harford-Wright, EM Galan-Moya, A Schmitt, S Azzi, ... Oncogene 35 (20), 2615-2623, 2016 | 120 | 2016 |
| Differential effects of 670 and 830 nm red near infrared irradiation therapy: a comparative study of optic nerve injury, retinal degeneration, traumatic brain and spinal cord … MK Giacci, L Wheeler, S Lovett, E Dishington, B Majda, CA Bartlett, ... PloS one 9 (8), e104565, 2014 | 59 | 2014 |
| Angiotensin-converting enzyme (ACE) inhibitors exacerbate histological damage and motor deficits after experimental traumatic brain injury E Harford-Wright, E Thornton, R Vink Neuroscience letters 481 (1), 26-29, 2010 | 51 | 2010 |
| Walker 256 tumour cells increase substance P immunoreactivity locally and modify the properties of the blood–brain barrier during extravasation and brain invasion KM Lewis, E Harford-Wright, R Vink, AJ Nimmo, MN Ghabriel Clinical & experimental metastasis 30, 1-12, 2013 | 36 | 2013 |
| Paracaspase MALT1 regulates glioma cell survival by controlling endo‐lysosome homeostasis KA Jacobs, G André‐Grégoire, C Maghe, A Thys, Y Li, E Harford‐Wright, ... The EMBO journal 39 (1), e102030, 2020 | 35 | 2020 |
| Treatment with the NK1 antagonist emend reduces blood brain barrier dysfunction and edema formation in an experimental model of brain tumors E Harford-Wright, KM Lewis, MN Ghabriel, R Vink PloS one 9 (5), e97002, 2014 | 32 | 2014 |
| Towards drug discovery for brain tumours: interaction of kinins and tumours at the blood brain barrier interface E Harford-Wright, K M Lewis, R Vink Recent Patents on CNS Drug Discovery (Discontinued) 6 (1), 31-40, 2011 | 29 | 2011 |
| Evaluating the role of substance P in the growth of brain tumors E Harford-Wright, KM Lewis, R Vink, MN Ghabriel Neuroscience 261, 85-94, 2014 | 27 | 2014 |
| HDAC3 regulates the transition to the homeostatic myelinating Schwann cell state LH Rosenberg, AL Cattin, X Fontana, E Harford-Wright, JJ Burden, ... Cell Reports 25 (10), 2755-2765. e5, 2018 | 23 | 2018 |
| NK1 receptor antagonists and dexamethasone as anticancer agents in vitro and in a model of brain tumours secondary to breast cancer KM Lewis, E Harford-Wright, R Vink, MN Ghabriel Anti-cancer drugs 24 (4), 344-354, 2013 | 20 | 2013 |
| β-escin selectively targets the glioblastoma-initiating cell population and reduces cell viability E Harford-Wright, N Bidère, J Gavard Oncotarget 7 (41), 66865, 2016 | 19 | 2016 |
| Characterisation of Walker 256 breast carcinoma cells from two tumour cell banks as assessed using two models of secondary brain tumours KM Lewis, E Harford-Wright, R Vink, MN Ghabriel Cancer cell international 13, 1-12, 2013 | 18 | 2013 |
| Desert Hedgehog/Patch2 axis contributes to vascular permeability and angiogenesis in glioblastoma S Azzi, L Treps, HM Leclair, HM Ngo, E Harford-Wright, J Gavard Frontiers in Pharmacology 6, 281, 2015 | 15 | 2015 |
| Apelin, the devil inside brain tumors E Harford-Wright, J Gavard Journal of experimental neuroscience 12, 1179069518759680, 2018 | 14 | 2018 |
| Targeting classical but not neurogenic inflammation reduces peritumoral oedema in secondary brain tumours KM Lewis, E Harford-Wright, R Vink, MN Ghabriel Journal of Neuroimmunology 250 (1-2), 59-65, 2012 | 12 | 2012 |
| The potential for substance P antagonists as anti-cancer agents in brain tumours E Harford-Wright, K M Lewis, R Vink Recent Patents on CNS Drug Discovery (Discontinued) 8 (1), 13-23, 2013 | 8 | 2013 |
| Advancing drug therapy for brain tumours: A current review of the pro-inflammatory peptide substance P and its antagonists as anti-cancer agents K Mander, E Harford-Wright, K M Lewis, R Vink Recent Patents on CNS Drug Discovery (Discontinued) 9 (2), 110-121, 2014 | 7 | 2014 |
| Neutralizing gp130 interferes with endothelial-mediated effects on glioblastoma stem-like cells KA Jacobs, E Harford-Wright, J Gavard Cell Death & Differentiation 24 (2), 384-384, 2017 | 5 | 2017 |
| Control of the endo-lysosome homeostasis by the paracaspase MALT1 regulates glioma cell survival KA Jacobs, G André-Grégoire, C Maghe, Y Li, A Thys, E Harford-Wright, ... bioRxiv, 582221, 2019 | 3 | 2019 |
